378 related articles for article (PubMed ID: 34796128)
1. Recent Advances on the Innate Immune Response to
Sireci G; Badami GD; Di Liberto D; Blanda V; Grippi F; Di Paola L; Guercio A; de la Fuente J; Torina A
Front Cell Infect Microbiol; 2021; 11():754455. PubMed ID: 34796128
[No Abstract] [Full Text] [Related]
2. Coxiella burnetii Lipopolysaccharide: What Do We Know?
Abnave P; Muracciole X; Ghigo E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
[TBL] [Abstract][Full Text] [Related]
3. Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection.
Elliott A; Peng Y; Zhang G
Infect Immun; 2013 Dec; 81(12):4604-14. PubMed ID: 24082077
[TBL] [Abstract][Full Text] [Related]
4. Cytometry profiling of
Raju Paul S; Scholzen A; Reeves PM; Shepard R; Hess JM; Dzeng RK; Korek S; Garritsen A; Poznansky MC; Sluder AE
Front Immunol; 2023; 14():1249581. PubMed ID: 37885896
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4.
Honstettre A; Ghigo E; Moynault A; Capo C; Toman R; Akira S; Takeuchi O; Lepidi H; Raoult D; Mege JL
J Immunol; 2004 Mar; 172(6):3695-703. PubMed ID: 15004173
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Caenorhabditis elegans innate immune response to Coxiella burnetii.
Battisti JM; Watson LA; Naung MT; Drobish AM; Voronina E; Minnick MF
Innate Immun; 2017 Feb; 23(2):111-127. PubMed ID: 27884946
[TBL] [Abstract][Full Text] [Related]
7. Role of innate and adaptive immunity in the control of Q fever.
Capo C; Mege JL
Adv Exp Med Biol; 2012; 984():273-86. PubMed ID: 22711637
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in innate immunity genes affect response to Coxiella burnetii and are associated with susceptibility to chronic Q fever.
Jansen AFM; Schoffelen T; Bleeker-Rovers CP; Wever PC; Jaeger M; Oosting M; Adriaans A; Joosten LAB; Netea MG; van Deuren M; van de Vosse E
Clin Microbiol Infect; 2019 May; 25(5):631.e11-631.e15. PubMed ID: 30616015
[TBL] [Abstract][Full Text] [Related]
9. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.
Shannon JG; Howe D; Heinzen RA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8722-7. PubMed ID: 15939879
[TBL] [Abstract][Full Text] [Related]
10. Syntaxin 11 Contributes to the Interferon-Inducible Restriction of Coxiella burnetii Intracellular Infection.
Ganesan S; Alvarez NN; Steiner S; Fowler KM; Corona AK; Roy CR
mBio; 2023 Feb; 14(1):e0354522. PubMed ID: 36728431
[TBL] [Abstract][Full Text] [Related]
11. Early cytokine and antibody responses against Coxiella burnetii in aerosol infection of BALB/c mice.
Schoffelen T; Self JS; Fitzpatrick KA; Netea MG; van Deuren M; Joosten LA; Kersh GJ
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):234-9. PubMed ID: 25618420
[TBL] [Abstract][Full Text] [Related]
12. Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.
Clemente TM; Mulye M; Justis AV; Nallandhighal S; Tran TM; Gilk SD
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30061378
[No Abstract] [Full Text] [Related]
13. Modulation of innate immune signaling by a
Burette M; Allombert J; Lambou K; Maarifi G; Nisole S; Di Russo Case E; Blanchet FP; Hassen-Khodja C; Cabantous S; Samuel J; Martinez E; Bonazzi M
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13708-13718. PubMed ID: 32482853
[TBL] [Abstract][Full Text] [Related]
14. Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever.
Kohl L; Siddique MNAA; Bodendorfer B; Berger R; Preikschat A; Daniel C; Ölke M; Liebler-Tenorio E; Schulze-Luehrmann J; Mauermeir M; Yang KT; Hayek I; Szperlinski M; Andrack J; Schleicher U; Bozec A; Krönke G; Murray PJ; Wirtz S; Yamamoto M; Schatz V; Jantsch J; Oefner P; Degrandi D; Pfeffer K; Mertens-Scholz K; Rauber S; Bogdan C; Dettmer K; Lührmann A; Lang R
EMBO Mol Med; 2023 Feb; 15(2):e15931. PubMed ID: 36479617
[TBL] [Abstract][Full Text] [Related]
15. TGF-β/IFN-γ Antagonism in Subversion and Self-Defense of Phase II Coxiella burnetii
Matthiesen S; Christiansen B; Jahnke R; Zaeck LM; Karger A; Finke S; Franzke K; Knittler MR
Infect Immun; 2023 Feb; 91(2):e0032322. PubMed ID: 36688662
[TBL] [Abstract][Full Text] [Related]
16. To die or not to die: Programmed cell death responses and their interactions with Coxiella burnetii infection.
Osbron CA; Goodman AG
Mol Microbiol; 2022 Apr; 117(4):717-736. PubMed ID: 35020241
[TBL] [Abstract][Full Text] [Related]
17. MyD88 Is Required for Efficient Control of
Kohl L; Hayek I; Daniel C; Schulze-Lührmann J; Bodendorfer B; Lührmann A; Lang R
Front Immunol; 2019; 10():165. PubMed ID: 30800124
[TBL] [Abstract][Full Text] [Related]
18. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.
Hedges JF; Robison A; Kimmel E; Christensen K; Lucas E; Ramstead A; Jutila MA
Infect Immun; 2016 Jun; 84(6):1815-1825. PubMed ID: 27068091
[TBL] [Abstract][Full Text] [Related]
19. Coxiella burnetii infection.
Kazar J
Ann N Y Acad Sci; 2005 Dec; 1063():105-14. PubMed ID: 16481501
[TBL] [Abstract][Full Text] [Related]
20. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
Shannon JG; Heinzen RA
Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
